Fundamentun, LLC Abb Vie Inc. Transaction History

Fundamentun, LLC

$1.34 Billion
Q3 2024

A detailed history of Fundamentun, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fundamentun, LLC holds 12,072 shares of ABBV stock, worth $2.14 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

12,072

Previous 12,037 0.29%

Holding current value

$2.14 Million

Previous $2.06 Million 15.46%

% of portfolio

0.18%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$163.84 - $199.33 $5,734 - $6,976	35 Added 0.29%	12,072 $2.38 Million
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $160,672 - $187,628	1,038 Added 9.44%	12,037 $2.06 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $365,188 - $416,098	-2,285 Reduced 17.2%	10,999 $2 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $35,913 - $40,447	-261 Reduced 1.93%	13,284 $2.06 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $129,047 - $149,391	966 Added 7.68%	13,545 $2.02 Million
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $135,027 - $168,033	1,019 Added 8.81%	12,579 $1.69 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $9,544 - $10,991	-66 Reduced 0.57%	11,560 $1.84 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $19,501 - $23,387	-141 Reduced 1.2%	11,626 $0
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $174,204 - $199,801	-1,298 Reduced 9.93%	11,767 $1.58 Million
Q2 2022 Sep 06, 2022	SELL	$137.62 - $174.96 $12,661 - $16,096	-92 Reduced 0.7%	13,065 $2 Million
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $73,380 - $91,045	556 Added 4.41%	13,157 $2.13 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $177,581 - $224,692	1,653 Added 15.1%	12,601 $1.71 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $265,042 - $300,862	2,491 Added 29.45%	10,948 $1.18 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $111,943 - $124,711	1,064 Added 14.39%	8,457 $953,000
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $254,931 - $280,649	-2,492 Reduced 25.21%	7,393 $800,000
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $103,590 - $139,858	1,287 Added 14.97%	9,885 $1.06 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $180,668 - $212,045	2,103 Added 32.38%	8,598 $753,000
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $147,473 - $197,341	2,010 Added 44.82%	6,495 $638,000
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $289,282 - $438,588	4,485 New	4,485 $342,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.

Account